|Articles|September 1, 2004
COX-2 inhibitors have potential for treating orbital disease
All patients demonstrated marked improvement of the redness, swelling, and inflammationassociated with thyroid orbitopathy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
From then to next: Five decades of transformation in ophthalmology
3
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
4
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
5














































.png)


